Medical Oncology Grand Rounds
2021-2022 Academic Year
| Date | Speaker | Title | |
| Sep 24, 2021 | Whitney Hensing | Targeting HER2 in Breast Cancer: New Drugs and Paradigms | |
| Oct 8, 2021 | Rigoberto Pizarro | Overview of Health Disparities in Cancer | |
| Fahrettin Covut | Minimal Residual Disease in Multiple Myeloma | ||
| Oct 15, 2021 | Raya Saba | Updates in Frontline Treatment of Chronic Lymphocytic Leukemia | |
| Andrew Young | Liquid Biopsy for Cancer Screening | ||
| Oct 22, 2021 | Eric Schwartz | Financial Burdens Surrounding Oral Cancer Therapy | |
| Oct 29, 2021 | Patricia Ribeiro Pereira | Non-Invasive Nuclear Imaging of Cancer Biology to Convert Non-Responders Into Responders | |
| Nov 5, 2021 | Melissa Reimers | Updates and Recent Advances in Renal Cell Carcinoma | |
| Nov 12, 2021 | Daniel Link | Clonal Hematopoiesis: Etiology and Evolution | |
| Nov 19, 2021 | Armin Ghobadi | Cellular Therapies for Cancer - A Primer and an Update | |
| Nov 26, 2021 | Canceled - Holiday |
||
| Dec 3, 2021 | Canceled - ASH Meeting |
||
| Dec 10, 2021 | Canceled - ASH Meeting |
||
| Dec 17, 2021 | Canceled |
||
| Dec 24, 2021 | Canceled - Holiday |
||
| Dec 31, 2021 | Canceled - Holiday |
||
| Jan 7, 2022 | Patrick White | Innovative Tools and Strategies for Enhancing Support for Your Oncology Patients and Caregivers | |
| Jan 14, 2022 | Canceled |
||
| Jan 21, 2022 | Matthew Walter | Clonal Evolution of Myelodysplastic Syndromes | |
| Jan 28, 2022 | Srivatsan Raghavan | The Tumor Microenvironment Drives Cell State, Plasticity, and Drug Response in Pancreatic Cancer | |
| Feb 4, 2022 | Sheila Stewart | Age-Related Stromal Changes Drive Tumor Progression | |
| Feb 11, 2022 | Giordano Cittolin-Santos | Neoadjuvant Immunotherapy in NSCLC | |
| Jared Cohen | The Changing Landscape of Treatment in DLBCL | ||
| Feb 18, 2022 | Ravi Vij | Multiple Myeloma: The Best Is Yet to Come! | |
| Feb 25, 2022 | Joshua Rubin | Adapting Cancer Treatment to Sex Differences in Cancer Biology | |
| Mar 4, 2022 | Jason Weber | Identification of Drivers and Vulnerabilities in Breast Cancer | |
| Mar 11, 2022 | Jing Wu | Translational Research in Developing a CDK9 Inhibitor Towards a Glioma Treatment | |
| Mar 18, 2022 | Canceled |
||
| Mar 25, 2022 | Bindiya Patel | Biomarkers to Guide Adjuvant Therapy in Early-Stage NSCLC | |
| Michael Kramer | The Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia | ||
| Apr 1, 2022 | Joseph Franses Massachusetts General Hospital |
Identifying and Targeting Metastatic and Microenvironmental Drivers in Hepatocellular Carcinoma | |
| Apr 8, 2022 | Todd Fehniger | Activate and Recollect: Training Natural Killer Cells for Cancer Immunotherapy | |
| Apr 15, 2022 | Jing Xi | A Silent Epidemic? – Disparities in Breast Cancer for Sexual and Gender Minority Women | |
| Apr 22, 2022 | Miriam Jacobs | Applications of Memory-Like Natural Killer Cells for Head and Neck Cancer Immunotherapy | |
| Apr 29, 2022 | Michael Gillette Broad Institute, Cambridge, MA |
Deep Integrated Proteogenomics Reveals New Biology and Therapeutic Vulnerabilities in Non-Small Cell Lung Cancer | |
| May 6, 2022 | Foluso Ademuyiwa and Mark Fiala | Racial Disparities in Oncology: Challenges and Opportunities | |
| May 13, 2022 | Michael Iglesia | Metastasis in Colorectal Cancer | |
| May 20, 2022 | Milan Chheda | Tuning In: A Review of Psychedelics for Patients With Cancer | |
| May 27, 2022 | Nicole Foley | T-Cell Lymphomas and HSCT | |
| Michael Slade | Why CARs Crash: CAR T Cell Treatment Failure and the PD-1/PD-L1 Axis | ||
| Jun 3, 2022 | Canceled - ASCO Meeting |
||
| Jun 10, 2022 | Timothy Ley | AML Proteomics and Interactomics | |
| Jun 17, 2022 | Omar Butt | The Intersection of the Blood Brain Barrier, Neuro-Inflammation, and Neuro-Degeneration in Neuro-Oncology | |
| Jun 24, 2022 | Charles Swanton Francis Crick Institute, London, UK |
Paul Calabresi K12 Visiting Professor Lung Cancer Evolution, Metastases and Immune Evasion: Insights From TRACERx |
